In Unanimous Decision Supreme Court Preserves Access To Controversial Mifepristone

Thursday, June 13 2024

Share this story:

FILE - Members of the Supreme Court sit for a new group portrait following the addition of Associate Justice Ketanji Brown Jackson, at the Supreme Court building in Washington, Oct. 7, 2022. Bottom row, from left, Justice Sonia Sotomayor, Justice Clarence Thomas, Chief Justice John Roberts, Justice Samuel Alito, and Justice Elena Kagan. Top row, from left, Justice Amy Coney Barrett, Justice Neil Gorsuch, Justice Brett Kavanaugh, and Justice Ketanji Brown Jackson. The Supreme Court is adopting its first code of ethics, in the face of sustained criticism over undisclosed trips and gifts from wealthy benefactors to some justices. The policy was issued by the court Monday.
AP Photo/J. Scott Applewhite, File
FILE - Members of the Supreme Court sit for a new group portrait following the addition of Associate Justice Ketanji Brown Jackson, at the Supreme Court building in Washington, Oct. 7, 2022. Bottom row, from left, Justice Sonia Sotomayor, Justice Clarence Thomas, Chief Justice John Roberts, Justice Samuel Alito, and Justice Elena Kagan. Top row, from left, Justice Amy Coney Barrett, Justice Neil Gorsuch, Justice Brett Kavanaugh, and Justice Ketanji Brown Jackson. The Supreme Court is adopting its first code of ethics, in the face of sustained criticism over undisclosed trips and gifts from wealthy benefactors to some justices. The policy was issued by the court Monday.

WASHINGTON (AP) — The U.S. Supreme Court on Thursday ruled unanimously to preserve access to the abortion pill mifepristone, a pill used in the most common way to end a pregnancy. The medication was used in nearly two-thirds of all abortions in the United States last year.

The ruling is the court's first abortion decision since conservative justices overturned Roe v. Wade two years ago.

The justices ruled that abortion opponents lacked the legal right to sue over the federal Food and Drug Administration’s approval of the medication, mifepristone, and the FDA’s subsequent actions to ease access to it.

Justice Brett Kavanaugh wrote for the court that “federal courts are the wrong forum for addressing the plaintiffs’ concerns about FDA’s actions.” Kavanaugh was part of the majority to overturn Roe.

The case had threatened to restrict access to mifepristone across the country, including in states where abortion remains legal.

© 2025 K-LOVE News

Share this story:

See All News